Clicky

Bumrungrad Hospital(BUHPF)

Description: Bumrungrad Hospital Public Company Limited (the “Company”) operates a private hospital business in Bangkok with the current capacity of 487 beds and over 4,500 outpatients per day. The Company is one of the leading healthcare providers in Thailand and in the Southeast Asian region, providing complete healthcare services for both outpatients and inpatients. The Company has always emphasized the importance of quality healthcare and experienced physicians and staff. Bumrungrad International Hospital, Bangkok is the first hospital in Asia to receive the US standard accreditation from the Joint Commission International (JCI). The hospital has also received JCI’s Clinical Care Program Certification (CCPC) for specialties programs including the Primary Stroke Program, Acute Myocardial Infarction, Diabetes Mellitus Type I and II and Chronic Kidney Disease Stage I to IV. Besides, the Company is the first hospital which was approved by Thai Hospital Accreditation (HA).


Keywords: Diabetes Healthcare Providers E Health Kidney Disease Stroke Chronic Kidney Disease Kidney Diabetes Mellitus Chronic Kidney The Joint Rcti Myocardial Infarction Bumrungrad International Hospital Infarction Acute Myocardial Infarction Accreditation International Hospital

Home Page: www.bumrungrad.com

33 Sukhumvit Soi 3 (Nana Nua)
Bangkok, 10110
Thailand
Phone: 66 2 066 8888


Officers

Name Title
Ms. Linda Lisahapanya Pres, MD & Exec. Director
Ms. Artirat Charukitpipat Chief Exec. Officer
Ms. Oraphan Buamuang Chief Financial Officer
Ms. Supawan Sirinuntawit Accounting Mang.
Mr. Daniel Kastner Chief Transformation Office & Head of IR
Dr. Aniello M. Sorrentino Ph.D. Corp. Chief Strategy Officer
Mr. David T. Boucher FACHE Chief Bus. Transformation Officer
Tanee Maneenut Chief Bus. Devel. Officer
Ms. Rangsima Thongdee Head of Internal Audit
Jeremy Ford Laboratory Research & Technology Director of Bumrungrad International Hospital

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 35.0877
Trailing PE: 50.2308
Price-to-Book MRQ: 9.4974
Price-to-Sales TTM: 0.2576
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks